Table 2.

Prognostic impact of AF in HF: summary of observational studies

AuthorSettingnLVEFMean follow-up%AFDeaths, n (%)p-value
SRAF
Middlekauff et alHTx390<35%265 days19123/315 (29)36/75 (48)<0.005
Stevenson et alHTx750<40%2.0 years22336/584 (45)104/160 (61)<0.01
Mahoney et alHTx234<45%1.1 years2726/171 (15)14/63 (22)NS
Ahmed et alMedicare Alabama944All4.0 years27439/711 (62)166/233 (71)<0.01
Wojtkowska et alBilaystok, Poland120<30%3.0 years5026/60 (43)33/60 (55)NS
Corell et alDanish HF clinic Network1,019<45%1.9 years26180/750 (24)89/269 (33)<0.05
Pai and VaradarajanLoma Linda VA8,931All2.5 years182164/7728 (28)529/1203 (44)<0.0001
Rivero-Ayerza et alEuroHeart Failure Survey10,701AllN/A43419/6027 (7)372/4674 (8)<0.05
Rusinaru et alSomme< France368>50%N/A36125/236 (53)84/132 (64)<0.05
Hamaguchi et alJapanese Registry data2,659All2.4 years35N/AN/ANS
Shotan et alNational HF Survey, Israel4,102All4 years331480/2734 (54.3)882/1359 (64.9)0.0001
  • AF = atrial fibrillation; HTx = heart transplantation; LVEF: left ventricular ejection fraction; NS = not significant; SR = sinus rhythm. Adapted with permission from Khan et al.7